As of 2024-10-03, the Relative Valuation of Epizyme Inc (EPZM) is (29.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.47 USD, the upside of Epizyme Inc based on Relative Valuation is -2123.2%.
The range of the Relative Valuation is (19.67) - (30.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 37.9x | 26.5x |
| Forward P/E multiples | 13.1x - 24.3x | 21.7x |
| Fair Price | (19.67) - (30.04) | (29.74) |
| Upside | -1438.2% - -2143.4% | -2123.2% |
| Date | P/E |